Product Description
Sovihep V is a fixed-dose combination of two direct-acting antiviral medicines, Sofosbuvir and Velpatasvir, by Zydus. It is prescribed for chronic hepatitis C virus (HCV) infection. Each bottle contains 28 tablets. This is a prescription-only medicine and must be used only as directed by a registered medical practitioner.
Key Benefits
Two antiviral actions in one tablet for chronic hepatitis C
Helps lower the amount of hepatitis C virus in the blood when taken as prescribed
Fixed-dose combination that simplifies the treatment schedule
Prescribed as a once-daily oral tablet
Made in India by Zydus, a well-known pharmaceutical company
28-tablet bottle covers one month of therapy at the standard once-daily dose
Key Ingredients & Their Uses
Sofosbuvir 400mg: Blocks the NS5B polymerase enzyme the hepatitis C virus needs to multiply.
Velpatasvir 100mg: Blocks the NS5A protein, which is involved in viral replication and assembly.
How to Use
Take exactly as prescribed by your doctor, including the dose and duration.
The usual dose is one tablet once daily, with or without food. Your doctor will decide the treatment length and whether other medicines are added.
Swallow the tablet whole with water at the same time each day.
Do not skip doses or stop early, even if you feel better.
If you miss a dose, follow your doctor's advice. Do not double the next dose.
Technical Specifications
Brand: Sovihep V
Product Name: Sovihep V Tablet
Product Type: Prescription Antiviral Medicine (Allopathic)
Composition: Sofosbuvir 400mg + Velpatasvir 100mg
Dosage Form: Film-coated Tablet
Net Quantity: 28 Tablets
Pack Type: Bottle
Suitable For: Adults, as prescribed by a doctor
Storage: Store below 30°C in a cool, dry place, away from sunlight
Country of Origin: India
Manufacturer: Zydus Lifesciences Limited (Zydus Cadila), Ahmedabad, Gujarat
